A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection

NCT04144855 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TQB3474 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.